Mesothelioma - Early versus Delayed Chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16586512

Enrollment

Registered

2002-08-19

Start date

1999-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mesothelioma Cancer Mesothelioma

Interventions

1. Best supportive care + chemotherapy at presentation versus 2. Best supportive care + chemotherapy when symptoms progress

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with histologically verified malignant mesothelioma - Performance status (PS) 0-2 - Asymptomatic or stable symptoms 2. Age at least 18 years

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026